News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
About the Author - Mark Terry

BioSpace News - By Mark Terry
Pfizer (PFE) Spins Off 4 of Its Best Drug Candidates Into a Startup With $103 Million 9/25/2017
3 Biotechs on Their Way to Monster Status 9/25/2017
Interim CEO Named Permanent Leader at Tango Therapeutics 9/25/2017
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon 9/22/2017
Bay Area's IMPAX Labs (IPXL) Surges on Merger Buzz 9/22/2017
Drug Giants Making Googly Eyes At 2 Small Biotechs 9/22/2017
Delcath Systems (DCTH) Struggles to Find Ways to Raise Cash and Stay in Business 9/22/2017
Sanofi (SNY) R&D Boss Thinks His Team is Ready to Survive Without Besties Regeneron (REGN) and Alnylam (ALNY) 9/21/2017
Startup Whiz Kid Vivek Ramaswamy Does it Again, Launches Bay Area Firm to Revolutionize Clinical Trials 9/21/2017
Why Struggling MannKind (MNKD) is Struggling No More 9/21/2017
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson (JNJ) 9/21/2017
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma 9/21/2017
Boston's Juniper Pharma Suspends Program, Cuts 8% of R&D Jobs and CMO Steps Down 9/20/2017
3 California Biotechs That Have Already Gained 300% or More This Year 9/20/2017
Harvard Biotech Guru, VCs Launch LifeMine With $55 Million Series A 9/20/2017
Biotech Startup Bonanza Continues as Disarm Therapeutics Emerges With $30 Million 9/20/2017
San Diego's Halozyme (HALO) Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb (BMY) and Roche (RHHBY) 9/19/2017
Former GlaxoSmithKline (GSK) CEO and R&D Boss Secure New Gigs at Biotech VC Firms 9/19/2017
Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist (MRK) Exec 9/19/2017
Bill & Melinda Gates Foundation Sinks $40 Million Into Immunocore for Infectious Disease R&D 9/19/2017
Show Me The Money: Bay Area’s Top 5 Venture Capital-Backed Biotechs 9/18/2017
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller 9/18/2017
This Regeneron (REGN) Drug Just Took Another Step Toward Blockbuster Status 9/15/2017
Hawaii's Boom in Biotech Jobs Lures Top Graduates 9/15/2017
Scientists: Is a Master’s Degree the New Bachelor’s Degree? 9/15/2017
Novartis AG (NVS) Unloads Former New York Space for $18 Million, Resold for $30 Million 9/15/2017
New Career Path Emerges in Immuno-Biotechnology 9/15/2017
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data 9/15/2017
Otonomy (OTIC) Slashes 33% of Staff After Failed Phase III Clinical Trial for Meniere’s Disease 9/14/2017
Bay Area Startup BridgeBio Quietly Snags $135 Million From a Bunch of Wall Street Firms 9/14/2017
Johnson & Johnson (JNJ) Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall 9/13/2017
Cytel to Hire 100+ Biostatisticians, Statistical Programmers and Data Managers in Expansion 9/13/2017
Alexion (ALXN) Wants a Fresh Start, Slashes 20% of Jobs and Will Move HQ to Boston 9/13/2017
Two Deaths Hit AbbVie (ABBV)'s Late-Stage RA Study 9/13/2017
Why This Bay Area Biotech Could be a Cash Cow for Investors 9/13/2017
ProQR Therapeutics (PRQR) Spins Out CNS-Focused Biotech, Amylon Therapeutics 9/12/2017
FDA's Gottlieb Has Big Plans to Get Drugs Approved Faster, Tackle Drug Development Costs 9/12/2017
Exiting Novartis AG (NVS) CEO Sets His Sights on Silicon Valley and Its Biotech Startups 9/11/2017
2 Biotechs That Could be the Next M&A Targets 9/11/2017
Eli Lilly (LLY) Chops 3,500 Jobs, Shuts Down 2 R&D Sites 9/11/2017
Genentech (RHHBY)'s Macular Degeneration Candidate Flunks Phase III Study 9/11/2017
Patient Dies in Cellectis (CLLS)' Groundbreaking CAR-T Trial, Forcing a Halt to Trials 9/11/2017
FDA Orders 6 Partial or Full Clinical Holds on Celgene (CELG)'s Blood Cancer Studies 9/8/2017
Patient Death Forces Alnylam (ALNY) to Suspend Dosing in Hemophilia Trial, Stock Plunges 9/8/2017
FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb (BMY)'s Opdivo-Based Combo Trials 9/8/2017
7 PDUFA Dates to Mark on Your Calendars for September 9/7/2017
Surprise Exit: Novartis AG (NVS) CEO to Retire and Return to Silicon Valley, R&D Head Named New Leader 9/7/2017
How Gilead (GILD) and Kite Pharma (KITE)'s Flirtation Became the Real Thing 9/6/2017
Meet the 4 VC-Backed Biotech Startups That Just Landed Space in Kendall Square 9/6/2017
Takeda (TKPYY) Jumps Into the Land of CAR-T R&D With New Tie-Up 9/6/2017
For Sale: Merck KGaA (MKGAF.PK) Healthcare Business, Slightly Used, $1Billion-Plus Value 9/5/2017
Why Bristol-Myers Squibb (BMY) Could be the Answer to Pfizer (PFE)'s Pipeline Woes 9/5/2017
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations 9/5/2017
Why Gilead (GILD) Could Take Out Juno (JUNO) But Face Major Competition From This Biotech Giant 9/1/2017
Effective Today: Cancer Biotech ImMAGE (IMMG) Shutters Operations 9/1/2017
Investors Wait with Bated Breath for AstraZeneca PLC (AZN)'s Cancer Trial Data Next Week 9/1/2017
Incyte (INCY) Discloses Promising New Data in Combo Drug Trial With Merck & Co. (MRK)'s Keytruda 9/1/2017
Rumor Alert: Struggling AstraZeneca PLC (AZN) Made a Pass at This $16 Billion Japanese Drugmaker Last Year 9/1/2017
Why This Tiny Biotech is Giving Cash to Amgen (AMGN) Researchers 9/1/2017
Fired Pfizer (PFE) Scientist Slated for 2 More Retractions, Bringing the Total to 7 9/1/2017
Daiichi Sankyo Denies AstraZeneca PLC (AZN) Courtship 8/31/2017
Cancer Startup Torque Therapeutics Nabs $21 Million and Sets Up Shop in Kendall Square 8/31/2017
Longtime Biogen (BIIB) Exec Jumps Ship to Become COO of Scangos' Bay Area Startup 8/30/2017
Acorda (ACOR) Plunges After the FDA Rejects Marketing App for Parkinson's Disease Drug 8/29/2017
Enumeral Biomedical (ENUM) Gets Evicted as it Winds Down Operations 8/29/2017
CSL Behring Scoops Up This U.S. Biotech for $416 Million 8/29/2017
Biogen (BIIB) Shows Off More Positive Alzheimer’s Trial Data 8/29/2017
Elon Musk's Biotech Quietly Nabs $27 Million to Stick Machines Into People's Brains 8/28/2017
Pfizer (PFE) Picks Dramatic Skyscraper for Its New HQ in the Big Apple 8/25/2017
Novartis AG (NVS) Pays $31 Million+ for XOMA  (XOMA)'s Failed Phase III Drug 8/25/2017
Adamas (ADMS) Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug 8/25/2017
Biotech Gene Therapy Startup Apic Bio Launches in Cambridge, Massachusetts 8/24/2017
Meet the 23-Year-Old Who's Gambling $22 Million on Anti-Aging R&D 8/24/2017
This Drug Could be the Most Crucial in Regeneron (REGN)'s Massive Pipeline 8/24/2017
Illumina (ILMN) Spins Out Forensic Genetics Business Into New Company, Verogen 8/24/2017
Altimmune Expands to New HQ With Plans for New Jobs 8/24/2017
Ionis Pharma (IONS) Urges Investors to Reject the Below-the-Market Offer By TRC Capital 8/24/2017
Mystery Phoenix-Based Biotech Nixes Relocation Plans But Seeks M&A 8/22/2017
These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates 8/22/2017
Why This Massachusetts Biotech Could be the Tesla of Healthcare 8/22/2017
New Jersey Startup Celularity Launches With Clinical Assets From Big Name Biotechs 8/22/2017
Sarepta (SRPT)’s Exondys 51 Saga Continues as More Details About FDA’s Criticism Uncovered 8/22/2017
How Roche (RHHBY)'s $300 Million Campus Transformation Targets the New Generation of Biotech Workers 8/22/2017
3 Hot Biotech Stocks That Cost Less than a Cup of Coffee 8/21/2017
Long-Time NIH Scientist to Head Up Early Discovery at Pfizer (PFE) Unit 8/18/2017
Meet the BioPharma Vet Frantically Raising Cash for His Biotech Startup Engage Therapeutics 8/18/2017
The 3 Absolute Best Biotech Stocks Right Now 8/18/2017
Biogen (BIIB) Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech 8/17/2017
Novo Nordisk A/S (NVO)’s Diabetes Drug Beats Out Eli Lilly (LLY)’s Trulicity in Phase III Trials 8/17/2017
Novartis AG (NVS) Lures Superstar Scientist Away From UCSF 8/17/2017
Gilead (GILD) to Unveil New SoCal Facility That Could House Up to 500 Employees 8/16/2017
Why Gilead (GILD) Might Not Make an Oncology Buy After All 8/16/2017
Bristol-Myers Squibb (BMY)'s Stock Topples as Kidney Cancer Drug Flunks Phase III Study 8/16/2017
Amazon (AMZN)'s Possible Strategy for Breaking Into the $560 Billion Pharma Market 8/15/2017
Warning for Scientists: Scammers are Giving Away NIH Grants 8/15/2017
Sihuan Pharma Opens Up R&D Shop in the San Francisco Bay Area 8/15/2017
FDA Puts in Place New Hiring Protocols for Foreign Scientists 8/15/2017
Pharma Giant Bristol-Myers Squibb (BMY) Plans Layoffs, Effective Oct. 6 8/15/2017
Ophthotech (OPHT)'s Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study 8/15/2017
130 Jobs Affected as Merck KGaA (MKGAF.PK) Relocates Accounting, Book-Keeping Team to Cut Costs 8/14/2017
Bleeding Money, Patrick Soon-Shiong’s NantHealth (NH) Restructures and Lays Off 300 8/14/2017
Novogen (NVGN) Restructures, Board to Take Pay Cuts 8/14/2017
Former Pfizer (PFE) Scientist-Led Startup Zai Lab Taps Banks for $150M IPO 8/14/2017
GlaxoSmithKline (GSK) Ditches Ionis Pharma (IONS)'s Inotersen and IONIS-FB-LRx 8/11/2017
Pfizer (PFE)'s Expansion into Gene Therapy Adds Jobs with $90,000 Salaries 8/11/2017
Celgene (CELG) Revamps Pact With Bay Area Biotech, No Acquisition Coming 8/11/2017
Regeneron (REGN) Heading for Another Hiring Ramp 8/11/2017
Happy Birthday, Vivek Ramaswamy—Here’s a $1.1 Billion Present 8/11/2017
Egalet Cuts Workforce By 40% in Expense Reduction Plan 8/10/2017
Bay Area’s Ardelyx (ARDX) Slashes 28% of Workforce in Restructuring 8/10/2017
Drumroll... New Company Prevail Therapeutics Launched 8/10/2017
Bay Area’s BioMarin (BMRN) Expands With The World's “First and Largest” Gene Therapy Manufacturing Plant 8/9/2017
Why Eli Lilly (LLY) Has the Strongest Reputation in the Life Sciences Industry 8/9/2017
Biopharma Provider SGS (SGSN) Creates New Jobs in 2017 Expansion 8/9/2017
This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb (BMY) 8/8/2017
New York's Saptalis Expands Production into New 28,000 Sq. Ft. Plant 8/8/2017
3 Biotechs Whose Q2 Reports Exceeded Expectations 8/8/2017
MyoKardia Shares Surge on Positive Phase II Results for Heart Muscle Disease 8/8/2017
Acorda (ACOR) Investor Urges for Company to Explore Sale 8/7/2017
GlaxoSmithKline (GSK) to Shift Neuro R&D Out of China to Philadelphia Research Hub 8/7/2017
United Therapeutics (UTHR) Shares Surge on Report of Bids for Company 8/7/2017
CRO vs. Big Pharma: Which is the Better Place to Work? 8/7/2017
Dynavax (DVAX) Shares Plunge on Delayed FDA Decision for Hep B Vaccine Heplisav 8/4/2017
According to Real Scientists, This is How You Get a Job in Biopharma 8/4/2017
With Baxalta (BXLT) Boosting Rare Drugs, Shire (SHPG) May Spin Off ADHD Drugs Business 8/4/2017
Biotech Startup Indalo Therapeutics Nabs $9M 8/4/2017
Seattle Genetics (SGEN) Nabs Bristol-Myers Squibb (BMY)’s Bothell MFG Facility, Plans to Offer Jobs to Current Employees 8/3/2017
Agios (AGIO), Celgene (CELG) Win Early FDA Approval for New Cancer Drug 8/3/2017
Top 10 Biotech Employers in Massachusetts by Job Listings 8/3/2017
Why You Want to Keep This Small $2 Biotech Stock On Your Radar 8/3/2017
Immuron CEO Thomas Liquard Resigns 8/3/2017
Geron (GERN) Under Pressure as Clinical Trial Changes Causes Delays 8/2/2017
Adare Pharma to Expand Its Manufacturing and Formulation R&D, Expects to Create 29 Jobs 8/1/2017
4 Hot Biotech Stocks in 2017 8/1/2017
Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials 8/1/2017
3 Under $30: These Biotech Stocks to Shake Up the Industry 8/1/2017
Amazon (AMZN) Has Top Secret 1492 Unit Working on Healthcare and Telemedicine 8/1/2017
Clementia to Launch IPO, Despite So-So Phase II Trials and Investor Skepticism 8/1/2017
LabCorp (LH) Scoops Up Giant CRO for Approximately $1.2 Billion Cash 8/1/2017
FDA Panel Votes to Recommend Dynavax (DVAX)'s Hepatitis B Vaccine; Hepsilav Can Compete With GlaxoSmithKline (GSK)'s Engerix-B 7/31/2017
2 Pharma Giants Pfizer (PFE) Could Make a Megadeal on Soon 7/31/2017
Illumina (ILMN) Accelerator in the Bay Area Makes Room for 5 New Biotech Startups 7/31/2017
CMOs Cringe as GlaxoSmithKline (GSK) Will be Cutting Its Use by 25% 7/31/2017
220 Employees Chopped as Astellas (ALPMY) Winds Down SoCal's Agensys, Inc. 7/28/2017
Rumor Alert: This Big Pharma Has Hired Bankers to Fend Off Deal-Hungry Suitors 7/28/2017
Alexion (ALXN) Redefines R&D Strategy, Discontinues Programs and Kills Deals With Moderna, Blueprint (BPMC) and Arbutus Biopharma (ABUS) 7/28/2017
Some GlaxoSmithKline (GSK) Critics Would Prefer Walmsley Broke Up the Company 7/28/2017
GlaxoSmithKline (GSK) CEO Kills 30+ Pre-Clinical and Clinical Programs 7/28/2017
Google (GOOG) Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily (GOOGL) Campus to Sweeten Deal 7/27/2017
Biogen (BIIB) May Cut Jobs, Shutter Facilities to Streamline Ops and Free Up $400 Million for R&D 7/27/2017
Eli Lilly (LLY) Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs 7/26/2017
3 Biotechs With Positive Technical Stock Readouts Ahead of Q2 Reports 7/26/2017
Boehringer Ingelheim Aims for 300 New Bay Area Jobs With $217 Million Expansion 7/26/2017
5 Biotechs With $45 Billion Worth of Not-Yet Approved Drugs in the Pipeline 7/25/2017
Brace Yourself: GlaxoSmithKline (GSK)'s New CEO Gets Ready to Overhaul the Drug Pipeline 7/25/2017
10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer 7/24/2017
Merz North America to Consolidate Three Facilities, Will Retain 165 Jobs and Hopes to Create More 7/24/2017
Corning (GLW), Merck & Co. (MRK) and Pfizer (PFE) to Invest $4 Billion and Create 4,000 New Jobs in the U.S. 7/24/2017
3 Sizzling Hot Biotech Stocks Only Likely to Get Hotter 7/21/2017
11 Life Science Skills You'll Need in 2020 7/21/2017
Can This Region Become the Country’s Next Big Biotech Hub for Jobs? 7/21/2017
Most Common Mistake Scientists Make When Applying for a Job 7/21/2017
Hundreds of Jobs to Go as GlaxoSmithKline (GSK) Shutters Manufacturing Site 7/21/2017
Uncertainty Hits as Roche (RHHBY) is Dealt Multiple Clinical Trial Setbacks 7/21/2017
Kite Pharma (KITE) Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy 7/21/2017
3 Big Pharmas That Give Investors the Biggest Bang for the Buck 7/20/2017
New GlaxoSmithKline (GSK) CEO Wants to Dump Another Business as it Prioritizes Pharma 7/20/2017
2 Fast-Rising Biotech Stocks With No Competition in Sight 7/20/2017
Takeda (TKPYY) Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston 7/20/2017
How Much Money Will These 5 Pharma Companies' Pipelines Generate in 5 Years 7/19/2017
3 Tiny Biotechs Packed With Top Execs With Proven Track Records 7/19/2017
Novartis AG (NVS) Boss Updates Q2 Financials and Reaffirms M&A Strategy 7/19/2017
Safety Issues Force the FDA to Turn Down Amgen (AMGN), UCB SA's Osteoporosis Drug 7/18/2017
This is the Fastest Growing Cancer Biotech No One Really Knows About 7/17/2017
How Biogen (BIIB) Makes Most of Its Cash 7/17/2017
Biotech Startup Ibex Biosciences Quietly Sets Up Shop in Maryland 7/17/2017
Debt-Ridden Valeant (VRX) Dumps Another Asset in $190 Million Cash Deal 7/17/2017
FDA Gives Nod to Johnson & Johnson (JNJ)'s Potential Blockbuster Psoriasis Med 7/17/2017
FDA Panel Unanimously Endorses Novartis AG (NVS)'s CAR-T Leukemia Drug 7/14/2017
GlaxoSmithKline (GSK) Poaches Another Top Exec—This Time From Pfizer (PFE) 7/14/2017
Novartis AG (NVS) Stocking Up on "Big-3" Arthritis Blockbusters to Get an Edge on Rivals 7/14/2017
Why This Bay Area Pharma Could Win the Hemophilia Race With 'One And Done' Drug 7/13/2017
San Diego's Arena (ARNA) Soars as Phase II Hypertension Trial Data Wows 7/13/2017
Sanofi (SNY) Finally Closes a Deal, Pays $750 Million for This Connecticut Biotech 7/13/2017
Bay Area's Galena Biopharma  (GALE) Slashes Jobs While Exploring Strategic Alternatives 7/12/2017
5 Best Biotech Stocks to Buy in the 2nd Half of 2017 7/12/2017
5 Cancer Drugs That Will Become Even Bigger Winners by 2022 7/12/2017
Booming C4 Therapeutics to Move Out of Pricey Kendall Square Next Year 7/12/2017
The 3 Biotechs That Could Make Celgene (CELG) Even Richer 7/11/2017
Why Amgen (AMGN) Needs an Acquisition to Keep Up with Immuno-Oncology Competitors 7/11/2017
Little-Known Emmaus Just Won Approval for First New Sickle Cell Drug in 20 Years 7/11/2017
CMC Biologics to Hire 100 to 150 Employees in Washington 7/10/2017
3 Under-the-Radar Biotech Clusters for Life Science Job Seekers 7/10/2017
What Does It Take to Get Hired by GlaxoSmithKline (GSK) and AbbVie (ABBV) 7/7/2017
Capricor (CAPR) Falls as Johnson & Johnson (JNJ) Bails on Stem Cell Heart Med 7/7/2017
Mark Your Calendars: 7 Biotechs Facing Important Catalysts in July 7/7/2017
Biotech Bestie Celgene (CELG) Takes Stake, Inks $1 Billion+ Deal With BeiGene (BGNE) 7/7/2017
Japan's Konica Minolta (4902) Takes Out SoCal Diagnostics Firm Ambry Genetics in $1 Billion Deal 7/7/2017
Effective Immediately: Advaxis (ADXS) CEO Resigns, Interim Leader Named 7/7/2017
Bristol-Myers Squibb (BMY)'s Opdivo Prevails in Phase III Melanoma Trial 7/6/2017